Blood Proteins FGF2 and PRDX3 Fail to Improve Long COVID Prediction Across Cohorts
A rigorous cross-cohort analysis finds that the blood proteins FGF2 and PRDX3, measured during acute COVID-19, do not reliably improve ...
A rigorous cross-cohort analysis finds that the blood proteins FGF2 and PRDX3, measured during acute COVID-19, do not reliably improve ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.